Download PDF
Horm Metab Res 2003; 35(5): 324-329
DOI: 10.1055/s-2003-41310
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

An Oestrogen-Producing Seminoma Responsible for Gynaecomastia

C.  Duparc 1 , G.  Boissiere-Veverka1 , H.  Lefebvre 1 , A.  Laquerriere 2 , P.  Vuillermet 1 , A.  Landreat 2 , R.  Ivell 3 , N.  DeRoux 4 , J.  M.  Kuhn 1
  • 1 European Institute for Peptide Research (IFRMP 23), Department of Endocrinology, INSERM U 413, University Hospital of Rouen, France
  • 2 Laboratory of Anatomopathology, University Hospital of Rouen, France
  • 3 Institute for Hormone and fertility research, University of Hamburg, Hamburg, Germany
  • 4 Laboratory of Hormonology and molecular Biology, University Hospital Bicêtre, Le Kremlin-Bicêtre, France
Further Information

Publication History

Received 15 July 2002

Accepted after Revision 3 December 2002

Publication Date:
13 August 2003 (online)

Also available at
    Permissions and Reprints

Abstract

In feminising testicular tumours, oestrogens can be either secreted by the tumour itself or produced by normal Leydig cells in response to paracrine and/or endocrine stimulation by hCG. Typical hormonal Leydig cell tumour patterns include: plasma oestradiol levels > 300 pmol/l on day 3 following an hCG injection, reduced plasma testosterone, and normal plasma hCG and gonadotrophin levels. Except for elevated plasma oestradiol levels, opposite results are observed in seminomas. We report a case of oestrogen-secreting seminoma mimicking a Leydig cell tumour. A 24-year-old Caucasian patient had complained of gynaecomastia for 6 months before admission. Hormonal pattern was typical of Leydig cell tumour. A 1.4 cm tumour was found in the left testis and confirmed on sonography. Considering the likely diagnosis of Leydig cell tumour, the patient was treated by tumourectomy. Surprisingly, pathological examination revealed a pure seminoma. Perifusion experiments showed that the tumour was able to secrete significant amounts of oestradiol. In addition, hCG induced a two-fold increase in oestradiol production from perifused tumour explants. Immunohistochemistry revealed that the tumour was composed of nests of seminoma cells intermingled with lymphoid infiltrates. Tumour cells also expressed aromatase, the hCG/LH receptor and the Leydig cell marker relaxin-like factor, but were βhCG-negative. These results demonstrate that a pure seminoma of the testis is able to synthesise and secrete oestrogens. They also illustrate that the body of proof favouring the diagnosis of feminising Leydig cell tumour of the testis is not rigorously specific.

Key words

Oestradiol - Seminoma - Aromatase - Gynaecomastia - Leydig Cell - Hybrid Tumour

References.

  • 1 Braunstein G D. Gynecomastia.  N Engl J Med. 1993;  328 490-495
    CrossrefPubMedGoogle Scholar
  • 2 Javadpour N, Mclntire K R, Waldmann T A. Human chorionic gonadotropin and alpha-feto-protein in sera and tumor cells of patients with testicular seminoma.  Cancer. 1978;  42 2768-2777
    PubMedGoogle Scholar
  • 3 Lefebvre H, Laquerriere A, Cleret J M, Kuhn J M. A hCG-secreting testicular seminoma revealed by male infertility: Mechanism of hCG-evoked endocrine disturbances.  Andrologia. 1993;  25 283-287
    PubMedGoogle Scholar
  • 4 Rajpert-De Meyts E, Toppari J, Skakkebaek N E. Testicular tumors with endocrine manifestations. In: DeGroot LJ, Jameson JL (ed) Endocrinology. Philadelphia; W. B. Saunders 2001: 2351-2356
    Google Scholar
  • 5 Aiginger P, Kolbe H, Kühbôck J, Spona J, Geyer G. The endocrinology of testicular germ cell tumours.  Acta Endocrinol. 1981;  97 419-426
    PubMedGoogle Scholar
  • 6 Mumperow E, Hartmann M. Spermatic cord β-human chorionic gonadotropin levels in seminoma and their clinical implications.  J Urol. 1992;  147 1041-1043
    PubMedGoogle Scholar
  • 7 Hainsworth J D, Greco F A. Testicular germ cell neoplasms.  Am J Med. 1983;  75 817-832
    CrossrefPubMedGoogle Scholar
  • 8 Bercovici J P, Tater D, Khoury S, Charles J F, Floch J, Leroy J P. Leydig cell tumor with gynecomastia: hormonal effects of an estrogen-producing tumor.  J Clin Endocrinol Metab. 1981;  53 1291-1296
    PubMedGoogle Scholar
  • 9 Kuhn J M, Mahoudeau J, Billaud L, Joly J, Rieu M, Gancel A, Archambeau-Mouveroux F, Steg A, Luton J P. Evaluation of diagnosis criteria for Leydig cell tumours in adult men revealed by gynaecomastia.  Clin Endocrinol. 1987;  26 407-416
    PubMedGoogle Scholar
  • 10 Reznik Y, Rieu M, Kuhn J M, Mandard J C, Bottet P, Lemonnier D, Bekka S, Mahoudeau J. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.  Clin Endocrinol. 1993;  38 487-493
    PubMedGoogle Scholar
  • 11 Hendry W F, Garvie W HH, Ah-See A K, Bagliss A P. Ultrasonic detection of occult testicular neoplasms in patients with gynaecomastia.  Br J Radiol. 1984;  57 572-573
    PubMedGoogle Scholar
  • 12 Hass G P, Pittabiga S, Gomella L. Clinically occult Leydig cell tumor presenting with gynecomastia.  J Urol. 1989;  142 1325-1327
    PubMedGoogle Scholar
  • 13 Mahoudeau J A, Luton J P, Bricaire H. Diagnostic d'une tumeur à cellules de Leydig par le test à la gonadotrophine chorionique (hCG).  Presse Méd. 1980;  9 536
    PubMedGoogle Scholar
  • 14 Lefebvre H, Contesse V, Delarue C, Feuilloley M, Hery F, Grise P, Raynaud G, Verhofstad A AJ, Wolf L M, Vaudry H. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype.  Neuroscience. 1992;  47 999-1007
    CrossrefPubMedGoogle Scholar
  • 15 Thorneycroft I H, Ribeiro W O, Stone S C, Tilison S A. A radioimmunoassay of androstenedione.  Steroids. 1973;  21 111-122
    CrossrefPubMedGoogle Scholar
  • 16 Furuyama S, Mayes D M, Nugent C A. A radioimmunoassay for plasma testosterone.  Steroids. 1972;  16 415-428
    PubMedGoogle Scholar
  • 17 Wu C H, Lundy L E. Radioimmunassay of plasma estrogens.  Steroids. 1971;  18 91-111
    PubMedGoogle Scholar
  • 18 Weinstein A, Lindner H R, Friedlander A, Bauminger S. Antigenic complexes of steroid hormones formed by coupling to protein through position 7: preparation from 4 - 3-oxosteroids and characterization of antibodies to testosterone and androstenedione.  Steroids. 1972;  20 789-812
    CrossrefPubMedGoogle Scholar
  • 19 Lindner H R, Perel E, Friedlander A, Zeitlin A. Specificity of antibodies to ovarian hormones in relation to the steroid hapten to the peptide carrier.  Steroids. 1972;  19 357-375
    CrossrefPubMedGoogle Scholar
  • 20 Ivell R, Balvers M, Domagalski R, Ungefroren H, Hunt N, Schulze W. Relaxin-like factor: a highly specific and constitutive new marker for Leydig cells in the human testis.  Mol Human Reprod. 1997;  3 459-466
    PubMedGoogle Scholar
  • 21 Meduri G, Charnaux N, Loosefelt H, Jolivet A, Spyratos F, Brailly S, Milgrom E. H, Bunick D, Hess RA. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer.  Cancer Res. 1997;  57 857-864
    PubMedGoogle Scholar
  • 22 Gabrilove J, Nicolis G L, Mitty H A, Sohval A R. Feminizing interstitial cell tumors of the testis: Personal observations and review of the literature.  Cancer. 1975;  35 1184-1202
    PubMedGoogle Scholar
  • 23 Manivel J C, Jessurun J, Wick M R, Dehner L P. Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms.  Am J Surg Pathol. 1987;  11 21-29
    PubMedGoogle Scholar
  • 24 Niehans G A, Manivel J C, Copland G T, Scheithauer B W, Wick M R. Immunohistochemistry of the germ cell and trophoblastic neoplasms.  Cancer. 1988;  62 1113-1123
    PubMedGoogle Scholar
  • 25 Kommoss F, Oliva E, Bittinger F, KirkPatrick C J, Amin M B, Bhan A K, Young R H, Scully R E. Inhibin-alpha, CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome.  Human Pathol. 2000;  31 1055-1061
    CrossrefPubMedGoogle Scholar
  • 26 Rieu M, Reznîk Y, Vannetzel J M, Mahoudeau J, Berrod J L, Kuhn J M. Testicular steroidogenesis in adult men with human chorionic gonadotropin-producing tumors.  J Clin Endocrinol Metab. 1995;  80 2404-2409
    CrossrefPubMedGoogle Scholar
  • 27 Augusto D, Leteurtre E, de la Taille A, Gosselin B, Leroy X. Calretinin : a valuable marker of normal and neoplastic Leydig cells of the testis.  Appl Immunohistochem Mol Morphol. 2002;  10 159-162
    CrossrefPubMedGoogle Scholar
  • 28 Ulbright T M, Srigley J R, Hatzianastassiou D K, Young R H. Leydig cell tumors of the testis with unusual features: adipose differentiation, calcification with ossification, and spindle-shaped tumor cells.  Am J Surg Pathol. 2002;  26 1424-1433
    CrossrefPubMedGoogle Scholar
  • 29 Cao Q J, Jones J G, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors.  Int J Gynecol Pathol. 2001;  20 46-352
    PubMedGoogle Scholar
  • 30 Busam K J, Iversen K, Coplan K A, Old L J, Stockert E, Chen Y T, McGregor D, Jungbluth A. Immunoreactivity for A101, an antibody to melan-A (MART-1) in adrenocortical and other steroid tumors.  Am J Surg Pathol. 1998;  22 57-63
    CrossrefPubMedGoogle Scholar
  • 31 Bergh A, Cajander S. Immunohistochemical localization of inhibin-alpha in the testes of normal men and in men with testicular disorders.  Int j Androl.. 1990;  13 463-469
    PubMedGoogle Scholar
  • 32 Hiroi N, Chrousos G P, Kohn B, Lafferty A, Abu-Asab M, Bonat S, White A, Bornstein S R. Adrenocortical-pituitary hybrid tumor causing Cushing's syndrome.  J Clin Endocrinol Metab. 2001;  86 2631-2637
    CrossrefPubMedGoogle Scholar
  • 33 Mathison D A, Waterhouse C A. Cushing's syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma).  Am J Med 1969. Oct ;  47 (4) 635-641
    PubMedGoogle Scholar
  • 34 Lacroix A, Ndiaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome.  Endocr Rev. 2001;  22 75-110
    CrossrefPubMedGoogle Scholar
  • 35 Brodie A, Insker S. Aromatase in the human testis.  J Steroid Biochem Mol Biol. 1993;  44 549-555
    CrossrefPubMedGoogle Scholar
  • 36 Insker S, Yue W, Brodie A. Human testicular aromatase: immunocytochemical and biochemical studies.  J Clin Endocrinol Metab. 1995;  80 1941-1947
    CrossrefPubMedGoogle Scholar
  • 37 Carreau S, Genissel C, Bilinska B, Levallet J. The estrogen sources in the testis and the reproductive tract of the male.  Int J Androl. 1999;  22 211-223
    CrossrefPubMedGoogle Scholar
  • 38 Janulis L, Bahr J M, Hess R A. Rat testicular germ cells and epididymal sperm contain active P450 aromatase.  J Androl. 1998;  19 65-71
    PubMedGoogle Scholar
  • 39 Bulun S E, Noble L S, Takayama K, Michael M D, Agarwal V, Fisher C, Zhao Y, Hinshelwood M M, Ito Y, Simpson E R. Endocrine disorders associated with inappropriately high aromatase expression.  J Steroid Biochem Mol Biol. 1997;  61 133-139
    CrossrefPubMedGoogle Scholar
  • 40 Agarwal V R, Takayama K, van WYK J J, Sasano H, Simpson E R, Bulun S E. Molecular basis of severe gynaecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinome.  J Clin Endocrinol Metab. 1998;  83 1797-1800
    CrossrefPubMedGoogle Scholar
  • 41 Harada N, Ota H, Yoshimura N, Katsuyama T, Takagi Y. Localized aberrant expression of cytochrome P450 aromatase in primary and metastatic malignant tumors of human liver.  J Clinl Endocrinol Metab. 1998;  83 697-702
    PubMedGoogle Scholar
  • 42 Young J, Bulun S E, Agarwal V, Couzinet B, Mendelson C R, Simpson E R, Schaison G. Aromatase expression in a feminizing adrenocortical tumor.  J Clin Endocrinol Metab. 1996;  81 3173-3176
    CrossrefPubMedGoogle Scholar
  • 43 O'Marcaigh A S, Ledger G A, Roche P C, Parisi J E, Zimmerman D. Aromatase expression in human germinomas with possible biological effects.  J Clin Endocrinol Metab. 1995;  80 3763-3766
    CrossrefPubMedGoogle Scholar
  • 44 Coen P, Kulin H, Ballantine T, Zaino R, Frauenhoffer E, Boal D, Insker S, Brodie A, Santen R. An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia.  N Engl J Med. 1991;  324 317-322
    CrossrefPubMedGoogle Scholar
  • 45 Young S, Gooneratne S, Straus F H, Zeller W P, Bulun S E, Rosenthal I M. Feminizing Sertoli cell tumors in boys wilh Peutz-Jeghers syndrome.  Am J Surg Pathol. 1995;  19 50-58
    PubMedGoogle Scholar
  • 46 Nakazumi H, Sasano H, Maehara I, Ozaki M, Tezuka F, Orikasa S. Estrogen metabolism and impaired spermatogenesis in germ cell tumors of the testis.  J Clin Endocrinol Metab. 1996;  81 1289-1295
    CrossrefPubMedGoogle Scholar
  • 47 Nitta H, Bunick D, Hess R A. Germ cells of the mouse testis express P450 aromatase.  Endocrinology. 1993;  132 1396-1401
    CrossrefPubMedGoogle Scholar

J. M. Kuhn, Pr.

IFRMP 23 · Department of Endocrinology · INSERM U 413 · Boisguillaume Hospital · CHU de Rouen

76031 Rouen cedex · France

Phone: + 33 (232) 88 90 82

Fax: + 33 (232) 88 91 54 ·

Email: jean-marc.kuhn@chu-rouen.fr